COMBINATION_PRODUCT · Unmapped registry intervention
200 mg of DPV + 320 mg LNG
Find medicine records ·
Find other trials using this name
Clinical trial
PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel
NCT02855346
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
COMBINATION_PRODUCT · Unmapped registry intervention
200 mg of DPV
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIV Preventionunresolved
Interventions
200 mg of DPV + 320 mg LNGCOMBINATION_PRODUCT
200 mg of DPVCOMBINATION_PRODUCT
Sponsors & collaborators
International Partnership for Microbicides, Inc.lead sponsor
National Institutes of Health (NIH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02855346 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.